This week, CBS News reported that Moderna's early data from their vaccine trials show 94.5% efficacy, with 5 vaccine recipients included in the trial's 95 confirmed cases, and…
Hana Niebur, MD, assistant professor at the University of Nebraska Children’s Hospital and Medical Center, discusses non-infectious complications of primary immune deficiency. Lung disease is the most common…
Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, creator of Little Thinkers Center in Los Angeles, and author of Productive, Successful YOU!, offers tips on setting up for success when you…
Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
In the rush to develop a viable vaccine to protect against COVID-19, what should patients expect in terms of timing, efficacy, and safety? George M. Abraham, MD, MPH,…
George M. Abraham, MD, MPH, FACP, FIDSA, Chair of the Infections Disease Board for the American Board of Internal Medicine, discusses the importance of social distancing and mask…
Donald B. Kohn, MD, of the University of California, Los Angeles, discusses hematopoietic stem cell gene therapy for primary immune deficiencies. Up to 89% of patients receiving hematopoietic…
Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Are aerosols traveling as much as 30 feet in poorly ventilated environments? As early as July 6, 2020, studies “have demonstrated beyond any reasonable doubt that viruses are…
